Feature | March 07, 2014 | Siddharth Saha

Digital Mammography’s Vital Role in Breast Care Screening

This article appeared as an introduction to a Comparison Chart on Digital Mammography in the March 2014 issue.

Criticism and confusion notwithstanding regarding the appropriateness of X-ray mammography as the gold standard in breast screening, digital mammography will continue to provide an important cog in the wheel of breast care pathways. The United States, some may say, is a slowing market for the digital mammography imaging modality due to a gradual decrease in the number of breast imaging facilities, reduction in replacement rates of mammography units and the possible linkage of reduced procedure numbers to the 2009 U.S. Preventive Services Task Force (USPSTF) recommendations.  

Work Horse in Breast Screening and Diagnostics

X-ray mammography, along with breast ultrasound, continues to account for the majority of breast diagnostics units sold to imaging departments in the United States, amounting to almost 90 percent of all units shipped. Breast magnetic resonance imaging (MRI) and molecular breast imaging (MBI) bring up the rest of the share. Within mammography, digital systems constitute roughly 80 percent of the installed base in the U.S. New mammography units have earned original equipment manufacturers (OEMs) roughly $350 million, and this figure is forecasted to grow at 6 percent over the next few years. Only MBI is growing at double-digit levels given the low penetration of this advanced capability.  

Technical Innovation to Drive Uptake Rates 

Research and statistics indicate the prevalence rate for breast cancer is increasing in the United States, partly attributable to the aging population. This demographic shift and the associated increase in breast cancer surgery necessitates the increase in presurgical images for intervention planning purposes. Regulatory changes such as the U.S. Food and Drug Administration’s (FDA) classification of full-field digital mammography (FFDM) from Class III to a Class II device category allowed for a faster and less stringent 510(k) submission process, resulting in a dramatic increase in the number of OEMs offering digital mammography in the United States. 

The healthy competition and portfolio of solutions offered by the OEMs has been forced to overcome industry challenges. The initial excitement has been somewhat muted from the noise created by conversations around the risks of the over-diagnosis of breast conditions by way of mass screening. This research has highlighted the negative implications of unnecessary breast care interventions in cases that do not warrant any further action. In addition, the 2009 USPSTF recommendations are said to have resulted in a decrease in utilization rates when it comes to breast screening. Though the verdict is still out there, when it comes to the above two restraints in the United States, what has been more telling on FFDM uptake rates is the response to budgetary pressures faced by hospital providers who are slightly reluctant to replace an already large installed base of digital systems. Diagnostic centers are now integrating other modalities into breast screening protocols due to the proven advantages of a multi-modality breast screening approach. Reimbursement cuts due to legislative changes as proposed in the Medicare Physician Fee Schedule (MPFS) and the advances in breast ultrasound in dense breast tissue cases have not helped FFDM either.

Continued technological innovation offered by leading OEMs in digital mammography will help retain the interest levels of breast care professionals who want to stay ahead of the curve in this industry sector. Digital breast tomosynthesis (DBT) is slated to become the next big thing in breast imaging. Hologic remains the only vendor with an FDA-approved system. This company can tout having a head start on the competition by getting an FDA approval for a 2013 upgrade on its Selenia Dimensions 3-D system, further enhancing its leading position in terms of sales units and customer feedback. Other vendors have focused on vital issues such as dosage control, as seen by the MicroDose system offered by Philips that is starting to penetrate the U.S. market. Other OEMs are focusing on software upgrades to break the monopoly in DBT. Software capabilities to measure breast tissue density, image visualization, image distribution and workflow optimization, including the enhancement of sensory perception and patient experience, are the other value additions offered by OEMs both established and new. All said and done, technological advances and the ability of the modality to integrate in a multi-modality system will determine the pecking order of digital mammography systems in breast care.  

Siddharth Saha is research director of advanced medical technologies for Frost & Sullivan.

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Women Prefer Getting Mammograms Every Year
News | Mammography | January 09, 2018
Women prefer to get their mammograms every year, instead of every two years, according to a new study presented at the...
Planmed Clarity 2-D Digital Mammography System Receives FDA Approval
Technology | Mammography | January 08, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the Planmed Clarity 2-D full-field digital...
Overweight Women May Need More Frequent Mammograms
News | Mammography | January 04, 2018
Women with higher body mass index (BMI) face an increased risk of not detecting their breast tumor until it has become...
About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

Feature | Breast Imaging | January 02, 2018 | Kathryn Pearson Peyton, M.D.
Sixty million women undergo regular screening mammography in the United States, but even in the digital age, it is di
Imagio Opto-Acoustic Breast Imaging System Helps Differentiate Tumor Subtypes
News | Oncology Diagnostics | January 02, 2018
Seno Medical Instruments Inc. (Seno Medical) recently reported data from their clinical study demonstrating that its...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Double Black Announces Gemini Series Monitors for Multimodality and Digital Breast Imaging
Technology | Flat Panel Displays | December 28, 2017
December 28, 2017 — Double Black Imaging and their Image Systems Division are releasing their Gemini Series 6MP and 8
Overlay Init